HUTCHMED (China) Limited
HCM.L · LSE
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Revenue | £630,201 | £837,999 | £426,409 | £356,128 |
| % Growth | -24.8% | 96.5% | 19.7% | – |
| Cost of Goods Sold | £348,884 | £686,448 | £311,103 | £258,234 |
| Gross Profit | £281,317 | £151,551 | £115,306 | £97,894 |
| % Margin | 44.6% | 18.1% | 27% | 27.5% |
| R&D Expenses | £212,109 | £302,001 | £267,587 | £207,447 |
| G&A Expenses | £64,296 | £79,784 | £92,173 | £89,298 |
| SG&A Expenses | £112,913 | £133,176 | £136,106 | £127,125 |
| Sales & Mktg Exp. | £48,617 | £53,392 | £43,933 | £37,827 |
| Other Operating Expenses | -£3,095 | -£302,001 | £119,306 | £91,639 |
| Operating Expenses | £321,927 | £133,176 | £522,999 | £426,211 |
| Operating Income | -£40,610 | £18,375 | -£407,693 | -£328,317 |
| % Margin | -6.4% | 2.2% | -95.6% | -92.2% |
| Other Income/Exp. Net | £0 | £87,228 | £47,024 | £173,194 |
| Pre-Tax Income | £45,362 | £105,603 | -£360,669 | -£155,123 |
| Tax Expense | £7,192 | £4,509 | -£283 | £11,918 |
| Net Income | £37,729 | £100,780 | -£360,835 | -£194,648 |
| % Margin | 6% | 12% | -84.6% | -54.7% |
| EPS | 0.044 | 0.12 | -0.43 | -0.25 |
| % Growth | -63.4% | 127.9% | -72% | – |
| EPS Diluted | 0.043 | 0.12 | -0.43 | -0.25 |
| Weighted Avg Shares Out | 860,033 | 849,661 | 792,685 | 792,685 |
| Weighted Avg Shares Out Dil | 872,534 | 869,196 | 792,685 | 792,685 |
| Supplemental Information | – | – | – | – |
| Interest Income | £40,080 | £36,145 | £9,599 | £2,076 |
| Interest Expense | £2,872 | £759 | £652 | £592 |
| Depreciation & Amortization | £12,341 | £8,207 | £8,664 | £7,190 |
| EBITDA | £14,106 | £67,274 | -£401,106 | -£321,127 |
| % Margin | 2.2% | 8% | -94.1% | -90.2% |